therapy-induced acute recruitment circulating endothelial progenitor cells tumors
contribution bone marrow-derived circulating endothelial progenitor cells ceps tumor angiogenesis controversial primarily low numbers blood vessels untreated tumors show treatment tumor-bearing mice vascular disrupting agents vdas leads acute mobilization ceps home viable tumor rim characteristically remains therapy disruption cep spike antiangiogenic drugs genetic manipulation resulted marked reductions tumor rim size blood flow well enhanced vda antitumor activity findings also provide mechanistic rationale enhanced efficacy vdas combined antiangiogenic drugs
